» Articles » PMID: 17690183

Early Axonopathy Preceding Neurofibrillary Tangles in Mutant Tau Transgenic Mice

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2007 Aug 11
PMID 17690183
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Neurodegenerative diseases characterized by brain and spinal cord involvement often show widespread accumulations of tau aggregates. We have generated a transgenic mouse line (Tg30tau) expressing in the forebrain and the spinal cord a human tau protein bearing two pathogenic mutations (P301S and G272V). These mice developed age-dependent brain and hippocampal atrophy, central and peripheral axonopathy, progressive motor impairment with neurogenic muscle atrophy, and neurofibrillary tangles and had decreased survival. Axonal spheroids and axonal atrophy developed early before neurofibrillary tangles. Neurofibrillary inclusions developed in neurons at 3 months and were of two types, suggestive of a selective vulnerability of neurons to form different types of fibrillary aggregates. A first type of tau-positive neurofibrillary tangles, more abundant in the forebrain, were composed of ribbon-like 19-nm-wide filaments and twisted paired helical filaments. A second type of tau and neurofilament-positive neurofibrillary tangles, more abundant in the spinal cord and the brainstem, were composed of 10-nm-wide neurofilaments and straight 19-nm filaments. Unbiased stereological analysis indicated that total number of pyramidal neurons and density of neurons in the lumbar spinal cord were not reduced up to 12 months in Tg30tau mice. This Tg30tau model thus provides evidence that axonopathy precedes tangle formation and that both lesions can be dissociated from overt neuronal loss in selected brain areas but not from neuronal dysfunction.

Citing Articles

Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer's Disease Model.

Ando K, Kosa A, Mehadji Y, Lasri H, Lopez-Gutierrez L, Quintanilla-Sanchez C Biomolecules. 2025; 15(2).

PMID: 40001463 PMC: 11853399. DOI: 10.3390/biom15020159.


The lemur tail kinase family in neuronal function and disfunction in neurodegenerative diseases.

Larose A, Miller C, Morotz G Cell Mol Life Sci. 2024; 81(1):447.

PMID: 39520508 PMC: 11550312. DOI: 10.1007/s00018-024-05480-0.


Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression.

Ando K, Kucukali F, Doeraene E, Nagaraj S, Antonelli E, Thazin Htut M Acta Neuropathol. 2024; 147(1):94.

PMID: 38833073 PMC: 11150309. DOI: 10.1007/s00401-024-02745-7.


Methods for Biochemical Isolation of Insoluble Tau in Rodent Models of Tauopathies.

Canet G, Rocaboy E, Diego-Diaz S, Whittington R, Julien C, Planel E Methods Mol Biol. 2024; 2754:323-341.

PMID: 38512674 DOI: 10.1007/978-1-0716-3629-9_17.


Behavioral, metabolic, and lipidomic characterization of the 5xFADxTg30 mouse model of Alzheimer's disease.

Marshall J, Huynh K, Lancaster G, Ng J, Collins J, Pernes G iScience. 2024; 27(2):108800.

PMID: 38292430 PMC: 10826307. DOI: 10.1016/j.isci.2024.108800.


References
1.
Ishihara T, Higuchi M, Zhang B, Yoshiyama Y, Hong M, Trojanowski J . Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments. J Neurosci. 2001; 21(16):6026-35. PMC: 6763173. View

2.
Stokin G, Lillo C, Falzone T, Brusch R, Rockenstein E, Mount S . Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science. 2005; 307(5713):1282-8. DOI: 10.1126/science.1105681. View

3.
Shankar S, Yanagihara R, Garruto R, Grundke-Iqbal I, Kosik K, Gajdusek D . Immunocytochemical characterization of neurofibrillary tangles in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Ann Neurol. 1989; 25(2):146-51. DOI: 10.1002/ana.410250207. View

4.
Condamines O, Mourton-Gilles C, Jakes R, Goedert M, Pau B, Delacourte A . AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Brain Res Mol Brain Res. 1996; 39(1-2):79-88. DOI: 10.1016/0169-328x(96)00003-4. View

5.
Rodgers-Johnson P, Garruto R, Yanagihara R, Chen K, Gajdusek D, Gibbs Jr C . Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam: a 30-year evaluation of clinical and neuropathologic trends. Neurology. 1986; 36(1):7-13. DOI: 10.1212/wnl.36.1.7. View